Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The effectiveness of maternal immunization in preventing infant pertussis was first demonstrated in England, 1 year after the program using diphtheria-tetanus-5-component acellular pertussis-inactivated polio vaccine (dT5aP-IPV) was introduced in 2012. Vaccine effectiveness against laboratory-confirmed pertussis has been sustained >90% in the 3 years following its introduction, despite changing to another acellular vaccine with different antigen composition. Consistent with this, disease incidence in infants <3 months of age has remained low despite high activity persisting in those aged 1 year and older. Vaccine effectiveness against infant deaths was estimated at 95% (95% confidence interval, 79%-100%). Additional protection from maternal immunization is retained in infants who received their first dose of the primary series. There is no longer evidence of additional protection from maternal vaccination after the third infant dose. Although numbers are small and ongoing assessment is required, there is no evidence of increased risk of disease after primary immunization in infants whose mothers received maternal vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Maternal vaccination with a pertussis-containing vaccine is now routinely recommended in several countries and has been shown to be safe and to result in high concentrations of antibody in the infant over the first 2 months of life (18–21).”
From Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy (2017) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of maternal pertussis vaccination in England: an observational study
Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Donegan, K., Fry, N. K., Miller, E., & Ramsay, M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60686-3 · Cited by 739 · cited 6×
“matched to the general practice of the cases [10, 11].”
BackgroundMethodInfluentialSelf-citationSawyer, M., Liang, J. L., Messonnier, N. E., & Clark, T. A. (2013) · MMWR Morbidity and Mortality Weekly Report · Cited by 722
Munoz, F. M., Bond, N. H., Maccato, M., Pinell, P., Hammill, H. A., Swamy, G. K., Walter, E. B., Jackson, L. A., Englund, J. A., Edwards, M. S., et al. (2014) · JAMA · doi:10.1001/jama.2014.3633 · Cited by 489
Dabrera, G., Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Fry, N. K., & Ramsay, M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu821 · Cited by 385 · cited 3×
“ceived vaccine at least 1 week prior to delivery, using both the screening method and case-control study approaches [10, 11], and this level of protection appears to have been sustained in the 3 years following the introduction of the program despite”
BackgroundMethodSelf-citationSafety of pertussis vaccination in pregnant women in UK: observational study
Donegan, K., King, B., & Bryan, P. (2014) · BMJ · doi:10.1136/bmj.g4219 · Cited by 281 · cited 1×
“servational study in the United Kingdom, which did not identify an increased risk for a range of maternal, fetal, and neonatal outcomes among almost 18 000 vaccinated pregnant women and their infants [12].”
BackgroundEstimation of Vaccine Effectiveness Using the Screening Method
FARRINGTON, C. P. (1993) · International Journal of Epidemiology · doi:10.1093/ije/22.4.742 · Cited by 261 · cited 1×
“Detailed methods have been previously described [10, 19].”
Eberhardt, C. S., Blanchard-Rohner, G., Lemaître, B., Boukrid, M., Combescure, C., Othenin-Girard, V., Chilin, A., Petre, J., de Tejada, B. M., & Siegrist, C.-A. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw027 · Cited by 253
Bogoch, I. I., Creatore, M. I., Cetron, M. S., Brownstein, J. S., Pesik, N., Miniota, J., Tam, T., Hu, W., Nicolucci, A., Ahmed, S., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61828-6 · Cited by 235
Ladhani, S. N., Andrews, N. J., Southern, J., Jones, C. E., Amirthalingam, G., Waight, P. A., England, A., Matheson, M., Bai, X., Findlow, H., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ695 · Cited by 180
Self-citationPertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study
Maertens, K., Caboré, R. N., Huygen, K., Hens, N., Van Damme, P., & Leuridan, E. (2016) · Vaccine · doi:10.1016/j.vaccine.2015.10.100 · Cited by 173
Hoang, H. T. T., Leuridan, E. E., Maertens, K., Nguyen, T. D., Hens, N., Vu, N. H., Caboré, R. N., Duong, H. T., Huygen, K., Damme, P. V., et al. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.098 · Cited by 145
Strategies to control pertussis in infants
Amirthalingam, G. (2013) · Archives of Disease in Childhood · doi:10.1136/archdischild-2012-302968 · Cited by 87 · cited 1×
“nized infants <3 months of age, with 14 pertussis-related infant deaths reported in the 2012 peak [8].”
BackgroundSelf-citationMaternal immunization in Argentina: A storyline from the prospective of a middle income country
Vizzotti, C., Neyro, S. E., Katz, N., Juárez, M. V. S., Carrega, M. E. P., Aquino, A., & Fullone, F. K. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.109 · Cited by 75
Cost-effectiveness and programmatic benefits of maternal vaccination against pertussis in England
van Hoek, A. J., Campbell, H., Amirthalingam, G., Andrews, N. J., & Miller, E. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.04.012 · Cited by 40 · cited 1×
“A recent analysis has indicated that while the cost effectiveness of this program is highly dependent on the future incidence of infant disease, which is uncertain, maternal vaccination is the only certain way of protecting vulnerable infants from birth [20].”
BackgroundSelf-citationImmunisation schedule of the Spanish Association of Paediatrics: 2015 Recommendations
Moreno‐Pérez, D., García, F. J. Á., Fernández, J. A., Ortega, M. J. C., Rauet, J. M. C., Sánchez, N. G., Merino, Á. H., Matos, T. H.-S., Moína, M. M., del Castillo, L. O., et al. (2015) · Anales de Pediatría (English Edition) · doi:10.1016/j.anpede.2014.10.002 · Cited by 38
Revised guidance on the choice of pertussis vaccines: July 2014.
(2014) · PubMed · Cited by 26
Fry, N. K., Litt, D. J., Duncan, J., Vaghji, L., Warrener, L., Samuel, D., Andrews, N. J., Harnden, A., & Harrison, T. G. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.062000-0 · Cited by 20 · cited 1×
“predefined threshold considered indication of recent infection and may be confounded by pertussis vaccination within the previous year [18].”
BackgroundSelf-citationImmunisation schedule of the Spanish Association of Paediatrics: 2016 recommendations
Moreno‐Pérez, D., García, F. J. Á., Fernández, J. A., Ortega, M. J. C., Rauet, J. M. C., Sánchez, N. G., Merino, Á. H., Matos, T. H.-S., Moína, M. M., del Castillo, L. O., et al. (2015) · Anales de Pediatría (English Edition) · doi:10.1016/j.anpede.2015.11.007 · Cited by 5
Research works printed but not linked: 1
- Maertens, 2015, Pertussis vaccination of pregnant women: rationale for the actual recommendations in Belgium, Tijdschrift Voor Geneeskunde, 71, 497
Cited by
Liang, J. L., Tiwari, T., Moro, P., Messonnier, N. E., Reingold, A., Sawyer, M., & Clark, T. A. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6702a1 · Cited by 457
Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis
Baxter, R., Bartlett, J., Fireman, B., Lewis, E., & Klein, N. P. (2017) · Pediatrics · doi:10.1542/peds.2016-4091 · Cited by 254
Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review
Vygen-Bonnet, S., Hellenbrand, W., Garbe, E., von Kries, R., Bogdan, C., Heininger, U., Röbl-Mathieu, M., & Harder, T. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4824-3 · Cited by 178
“Five [16, 43, 45, 47, 49] of the eight studies were judged as having a serious RoB, while three studies had a moderate RoB [44, 46, 48].”
BackgroundResultInfluentialWilcox, C. R., Holder, B., & Jones, C. E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01294 · Cited by 200
Update on Transplacental Transfer of IgG Subclasses: Impact of Maternal and Fetal Factors
Clements, T., Rice, T. F., Vamvakas, G., Barnett, S., Barnes, M., Donaldson, B., Jones, C. E., Kampmann, B., & Holder, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01920 · Cited by 163
Metadata
- Authors
- Amirthalingam, G., Campbell, H., Ribeiro, S., Fry, N. K., Ramsay, M., Miller, E., & Andrews, N.
- Affiliations
- Public Health England (GB)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-11-12
- Volume
- 63
- Issue
- suppl 4
- Pages
- S236-S243
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5106626
- OpenAlex
- W2554060857
- Cited by
- 275
- References
- 20
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 10 · 2023: 23 · 2022: 21 · 2021: 54 · 2020: 38 · 2019: 34 · 2018: 39 · 2017: 26
- FWCI
- 33.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Clinical Infectious Diseases (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Funders
- Public Health England
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Infectious Diseases › Diphtheria, Corynebacterium, and Tetanus
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- acellular pertussis vaccine, vaccine effectiveness, infant pertussis prevention, infant mortality, vaccine safety, disease incidence, England
- MeSH terms
- Adult, England, Female, Humans, Immunization Schedule, Infant, Infant, Newborn, Male, Mortality, Population Surveillance, Vaccination, Whooping Cough, Diphtheria-Tetanus-Pertussis Vaccine, Incidence, Outcome Assessment, Health Care, Immunization Programs, Maternal Exposure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.